Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dean G. Karalis
Prescribing Patterns of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in Eligible Patients With Clinical Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia
American Journal of Cardiology
Cardiovascular Medicine
Cardiology
Related publications
Lipoprotein(a) and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors
Clinical Research in Cardiology Supplements
Nuclear Medicine
Radiology
Molecular Biology
Structural Biology
Imaging
Medicine
Lipoprotein(a) and Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
Management of Patients Eligible for Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: Economic Impact and Reform Proposals
Global and Regional Health Technology Assessment
Health Policy
The Proprotein Convertases in Hypercholesterolemia and Cardiovascular Diseases: Emphasis on Proprotein Convertase Subtilisin/Kexin 9
Pharmacological Reviews
Molecular Medicine
Pharmacology
Cost Effectiveness of Proprotein Convertase Subtilisin/ Kexin Type 9 (PCSK9) Inhibitors
Cardiovascular Disorders and Medicine
Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK-9) Inhibitors Induced Liver Injury - A Retrospective Analysis
Journal of Community Hospital Internal Medicine Perspectives
Internal Medicine
PCSK6 (Proprotein Convertase Subtilisin/Kexin Type 6)
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Variations of the Proprotein Convertase Subtilisin/Kexin Type 9 Gene in Coronary Artery Disease
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology
Efficacy and Safety of Proprotein Convertase Subtilisin/Kexin 9 Inhibitors in People With Diabetes and Dyslipidaemia
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
